These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 24680441)

  • 41. Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy.
    Liss MA; Taylor SA; Batura D; Steensels D; Chayakulkeeree M; Soenens C; Rao GG; Dash A; Park S; Patel N; Woo J; McDonald M; Nseyo U; Banapour P; Unterberg S; Ahlering TE; Van Poppel H; Sakamoto K; Fierer J; Black PC
    J Urol; 2014 Dec; 192(6):1673-8. PubMed ID: 24928266
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antimicrobial prophylaxis protocol based on rectal swab culture before prostate biopsy to prevent infectious complications: a prospective randomized comparative study.
    Bouzouita A; Rehaiem A; Saadi A; Zaghbib S; Chakroun M; Ayed H; Ferjani A; Derouiche A; Boubaker IB; Slama MRB
    Int Urol Nephrol; 2024 Aug; 56(8):2495-2502. PubMed ID: 38448785
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy--should we reassess our practices for antibiotic prophylaxis?
    Steensels D; Slabbaert K; De Wever L; Vermeersch P; Van Poppel H; Verhaegen J
    Clin Microbiol Infect; 2012 Jun; 18(6):575-81. PubMed ID: 21958149
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeted antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy during active surveillance: Effect on hospitalization.
    Cheung C; Patel HD; Landis P; Carter HB; Han M
    Urol Oncol; 2018 Apr; 36(4):158.e7-158.e12. PubMed ID: 29288004
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transrectal povidone-iodine efficiency in reducing infections occurring after transrectal ultrasound guided biopsy of the prostate.
    Siyez E
    Medicine (Baltimore); 2021 Oct; 100(41):e27539. PubMed ID: 34731153
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidence and management of extended-spectrum beta-lactamase and quinolone-resistant Escherichia coli infections after prostate biopsy.
    Song W; Choo SH; Sung HH; Han DH; Jeong BC; Seo SI; Jeon SS; Lee KS; Lee SW; Lee HM; Choi HY; Jeon HG
    Urology; 2014 Nov; 84(5):1001-7. PubMed ID: 25443894
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy.
    Young JL; Liss MA; Szabo RJ
    Urology; 2009 Aug; 74(2):332-8. PubMed ID: 19464041
    [TBL] [Abstract][Full Text] [Related]  

  • 48. One preoperative dose randomized against 3-day antibiotic prophylaxis for transrectal ultrasonography-guided prostate biopsy.
    Briffaux R; Coloby P; Bruyere F; Ouaki F; Pires C; Doré B; Irani J
    BJU Int; 2009 Apr; 103(8):1069-73; discussion 1073. PubMed ID: 19021604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical importance of the antibiotic regimen in transrectal ultrasound-guided biopsy: quinolone versus cephalosporin.
    Lee JK; Lee S; Hong SK; Byun SS; Lee SE
    BMC Urol; 2016 Aug; 16(1):51. PubMed ID: 27557527
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk factors for and prophylactic effect of povidone-iodine rectal cleansing on infectious complications after prostate biopsy: a retrospective cohort study.
    Hwang EC; Jung SI; Seo YH; Jeong SH; Kwon DD; Park K; Kim JW
    Int Urol Nephrol; 2015 Apr; 47(4):595-601. PubMed ID: 25712677
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of targeted prophylactic antimicrobial therapy before transrectal ultrasonography-guided prostate biopsy in reducing infection rates: a systematic review.
    Cussans A; Somani BK; Basarab A; Dudderidge TJ
    BJU Int; 2016 May; 117(5):725-31. PubMed ID: 26709240
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical and microbiological determinants of infection after transrectal prostate biopsy.
    Liss MA; Johnson JR; Porter SB; Johnston B; Clabots C; Gillis K; Nseyo U; Holden M; Sakamoto K; Fierer J
    Clin Infect Dis; 2015 Apr; 60(7):979-87. PubMed ID: 25516194
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of Different Rectal Cleansing Methods for Reducing Post-Procedural Infectious Complications After Transrectal Ultrasound-Guided Prostate Biopsy.
    Lee JE; Shin SS; Kang TW; Kim JW; Heo SH; Jeong YY
    Urol J; 2020 Jan; 17(1):36-41. PubMed ID: 30882162
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of combined prophylactic use of levofloxacin and isepamicin for transrectal prostate needle biopsy: A retrospective single-center study.
    Nakagawa R; Shigehara K; Aoyama S; Urata S; Ofude M; Miyagi T; Nakashima T; Izumi K; Mizokami A
    J Infect Chemother; 2019 May; 25(5):337-340. PubMed ID: 30718193
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative Effectiveness of Targeted vs Empirical Antibiotic Prophylaxis to Prevent Sepsis from Transrectal Prostate Biopsy: A Retrospective Analysis.
    Liss MA; Kim W; Moskowitz D; Szabo RJ
    J Urol; 2015 Aug; 194(2):397-402. PubMed ID: 25846415
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combined ciprofloxacin and amikacin prophylaxis in the prevention of septicemia after transrectal ultrasound guided biopsy of the prostate.
    Kehinde EO; Al-Maghrebi M; Sheikh M; Anim JT
    J Urol; 2013 Mar; 189(3):911-5. PubMed ID: 23009873
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rectal culture-directed antibiotic prophylaxis before transrectal prostate biopsy: Reduced infectious complications and healthcare costs.
    Baldissera-Aradas JV; Rodríguez-Villamil L; Blanco-Fernández R; Pérez-García C; Viejo de la Guerra G; González-Rodríguez I; Mosquera-Madera J
    Actas Urol Esp (Engl Ed); 2018 Sep; 42(7):465-472. PubMed ID: 29331324
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy.
    Liss MA; Chang A; Santos R; Nakama-Peeples A; Peterson EM; Osann K; Billimek J; Szabo RJ; Dash A
    J Urol; 2011 Apr; 185(4):1283-8. PubMed ID: 21334021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rectal Culture-Based Versus Empirical Antibiotic Prophylaxis to Prevent Infectious Complications in Men Undergoing Transrectal Prostate Biopsy: A Randomized, Nonblinded Multicenter Trial.
    Tops SCM; Kolwijck E; Koldewijn EL; Somford DM; Delaere FJM; van Leeuwen MA; Breeuwsma AJ; de Vocht TF; Broos HJHP; Schipper RA; Steffens MG; Teerenstra S; Wegdam-Blans MCA; de Brauwer E; van den Bijllaardt W; Leenders ACAP; Sedelaar JPM; Wertheim HFL
    Clin Infect Dis; 2023 Apr; 76(7):1188-1196. PubMed ID: 36419331
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multi-drug resistant E.coli urosepsis in physicians following transrectal ultrasound guided prostate biopsies--three cases including one death.
    Carlson WH; Bell DG; Lawen JG; Rendon RA
    Can J Urol; 2010 Apr; 17(2):5135-7. PubMed ID: 20398457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.